Prognose des Bioproduktionsmarktes in Süd- und Mittelamerika bis 2030 – Regionale Analyse – nach Produkt (Biologika und Biosimilars, Impfstoffe, Zell- und Gentherapien, Nukleinsäuretherapeutika und andere), Anwendung (rheumatoide Arthritis, hämatologische Erkrankungen, Krebs, Diabetes, Herz-Kreislauf-Erkrankungen und andere), Ausrüstung (Upstream-Ausrüstung, Downstream-Ausrüstung, Bioreaktoren sowie Verbrauchsmaterialien und Zubehör) und Endverbraucher (Biopharmazeutische Unternehmen, Auftragshersteller und andere)
Patentablauf von Blockbuster-Biologika treibt Bioproduktionsmarkt in Süd- und Mittelamerika an
Biologika stellen vielversprechende neue Therapien für bislang unheilbare Krankheiten dar und gewinnen auf dem Pharmamarkt zunehmend an Bedeutung. Patente auf Original-Biologika laufen voraussichtlich in den kommenden Jahren aus.
Die geschätzten Patent- und Exklusivitätsablaufdaten für die meistverkauften Biologika sind in der folgenden Tabelle aufgeführt.
Biologika
Verfallsdaten
Avastin
Januar 2022
Cyramza
Mai 2023
Adcetris
August 2023
Abthrax
Oktober 2024
Gazyva/Gazyvaro
November 2024
Darzalex
Mai 2026
Ocrevus
April 2027
Emgality
September 2028
Hemlibra
Februar 2028
Llumetri
März 2028
Imfinzi
September 2028
Mylotarg
April 2028
Imfinzi
September 2028
Mylotarg
April 2028
Sylvant
Juli 2034
Der Ablauf des Patents und anderer Rechte an geistigem Eigentum für Original-Biologika wird in Zukunft die Einführung neuer Biosimilars erforderlich machen. Infolgedessen wird der Wettbewerb zwischen den Marktteilnehmern in der Branche in den kommenden Jahren zunehmen. Daher wird erwartet, dass der Ablauf des Patents für Blockbuster-Biologika im Prognosezeitraum lukrative Möglichkeiten für den Bioproduktionsmarkt schaffen wird.
Überblick über den Bioproduktionsmarkt in Süd- und Mittelamerika
Der Bioproduktionsmarkt in Süd- und Mittelamerika ist in Brasilien, Argentinien und den Rest von Süd- und Mittelamerika unterteilt. Wachsende Entwicklungen in der Medizinbranche und ein zunehmendes Bewusstsein für Zelltherapie in Brasilien werden wahrscheinlich erhebliche Wachstumschancen für das Marktwachstum schaffen. Ebenso wird erwartet, dass die wachsende Gesundheitsbranche in Argentinien Wachstumschancen für den Bioproduktionsmarkt bietet.
Laut einem in Biomaterials Research veröffentlichten Artikel gehörte Brasilien im Jahr 2020 zu den zehn Ländern der Welt mit der höchsten Zahl an Diabetikern und belegt derzeit den fünften Platz. Derzeit ist Brasilien das fünftgrößte Land der Welt mit der höchsten Prävalenz von Diabetes mellitus (DM) bei Erwachsenen. Nach Angaben der International Diabetes Federation (IDF) wird bis 2045 ein Anstieg der neuen Diabetesfälle um 54,7 % erwartet.
Laut GaBI hat die brasilianische Gesundheitsbehörde (Agência Nacional de Vigilância Sanitária, ANVISA) im Jahr 2022 30 Biosimilars in den Produktklassen Insulin, monoklonale Antikörper, Tumornekrosefaktor (TNF)-Hemmer, menschliches Wachstumshormon, Antikoagulanzien und Heparine sowie Granulozyten-Kolonie-stimulierender Faktor zur Verwendung in Brasilien zugelassen. Die ANVISA hat das Admelog-Biosimilar von Sanofi in Brasilien zur Behandlung von Diabetes zugelassen. Somit treiben wachsende Diabetesfälle und zunehmende Produktzulassungen in Brasilien den Bioproduktionsmarkt an.
Umsatz und Prognose des Bioproduktionsmarkts in Süd- und Mittelamerika bis 2030 (Mio. USD)
Segmentierung des Bioproduktionsmarkts in Süd- und Mittelamerika
Der Bioproduktionsmarkt in Süd- und Mittelamerika ist nach Produkt, Anwendung, Ausrüstung, Endbenutzer und Land kategorisiert.
Basierend auf dem Produkt ist der Bioproduktionsmarkt in Süd- und Mittelamerika in Biologika und Biosimilars, Impfstoffe, Zell- und Gentherapien, Nukleinsäuretherapeutika und andere segmentiert. Das Segment Biologika und Biosimilars hatte 2022 den größten Marktanteil an der Bioproduktion in Süd- und Mittelamerika.
In Bezug auf die Anwendung ist der Bioproduktionsmarkt in Süd- und Mittelamerika in rheumatoide Arthritis, hämatologische Erkrankungen, Krebs, Diabetes, Herz-Kreislauf-Erkrankungen und andere segmentiert. Das Segment Krebs hatte 2022 den größten Marktanteil an der Bioproduktion in Süd- und Mittelamerika.
Nach Ausrüstung ist der Bioproduktionsmarkt in Süd- und Mittelamerika in Upstream-Ausrüstung, Downstream-Ausrüstung, Bioreaktoren sowie Verbrauchsmaterialien und Zubehör unterteilt. Das Segment Verbrauchsmaterialien und Zubehör hatte 2022 den größten Marktanteil an der Bioproduktion in Süd- und Mittelamerika.
In Bezug auf den Endverbraucher ist der Bioproduktionsmarkt in Süd- und Mittelamerika in biopharmazeutische Unternehmen, Auftragsfertigungsorganisationen und andere unterteilt. Das Segment der biopharmazeutischen Unternehmen hatte 2022 den größten Marktanteil an der Bioproduktion in Süd- und Mittelamerika.
Nach Ländern ist der Bioproduktionsmarkt in Süd- und Mittelamerika in Brasilien, Argentinien und den Rest von Süd- und Mittelamerika unterteilt. Brasilien dominierte 2022 den Marktanteil an der Bioproduktion in Süd- und Mittelamerika.
Lonza Group AG, Danaher Corp, Sartorius AG, Thermo Fisher Scientific Inc, Merck KGaA, F. Hoffmann-La Roche Ltd und Bio-Rad Laboratories Inc. sind einige der führenden Unternehmen auf dem Bioproduktionsmarkt in Süd- und Mittelamerika.
Table of Content
1. Introduction
1.1 The Insight Partners Research Report Guidance
1.2 Market Segmentation
2. Executive Summary
2.1 Key Insights
3. Research Methodology
3.1 Coverage
3.2 Secondary Research
3.3 Primary Research
4. South & Central America Bioproduction Market - Key Industry Dynamics
4.1 Market Drivers
4.1.1 Rising Adoption of Regenerative Medicines
4.1.2 Increasing Prevalence of Chronic Diseases
4.2 Market Restraints
4.2.1 High Cost of Cell Therapy and Biosimilar Manufacturing
4.3 Market Opportunities
4.3.1 Patent Expiry of Blockbuster Biologics
4.4 Future Trends
4.4.1 Shift Toward Automated Cell Therapy Manufacturing
4.5 Impact Analysis
5. Bioproduction Market - South & Central America Market Analysis
5.1 South & Central America Bioproduction Market Revenue (US$ Mn), 2020 - 2030
6. South & Central America Bioproduction Market - Revenue and Forecast to 2030 - by Product
6.1 Overview
6.2 South & Central America Bioproduction Market Revenue Share, by Product 2022 & 2030 (%)
6.3 Biologics and Biosimilars
6.3.1 Overview
6.3.2 Biologics and Biosimilars: South & Central America Bioproduction Market - Revenue and Forecast to 2030 (US$ Million)
6.4 Vaccines
6.4.1 Overview
6.4.2 Vaccines: South & Central America Bioproduction Market - Revenue and Forecast to 2030 (US$ Million)
6.5 Cell and Gene Therapies
6.5.1 Overview
6.5.2 Cell and Gene Therapies: South & Central America Bioproduction Market - Revenue and Forecast to 2030 (US$ Million)
6.6 Nucleic Acid Therapeutics
6.6.1 Overview
6.6.2 Nucleic Acid Therapeutics: South & Central America Bioproduction Market - Revenue and Forecast to 2030 (US$ Million)
6.7 Others
6.7.1 Overview
6.7.2 Others: South & Central America Bioproduction Market - Revenue and Forecast to 2030 (US$ Million)
7. South & Central America Bioproduction Market - Revenue and Forecast to 2030 - by Application
7.1 Overview
7.2 South & Central America Bioproduction Market Revenue Share, by Application 2022 & 2030 (%)
7.3 Cancer
7.3.1 Overview
7.3.2 Cancer: South & Central America Bioproduction Market - Revenue and Forecast to 2030 (US$ Million)
7.4 Cardiovascular Diseases
7.4.1 Overview
7.4.2 Cardiovascular Diseases: South & Central America Bioproduction Market - Revenue and Forecast to 2030 (US$ Million)
7.5 Rheumatoid Arthritis
7.5.1 Overview
7.5.2 Rheumatoid Arthritis: South & Central America Bioproduction Market - Revenue and Forecast to 2030 (US$ Million)
7.6 Hematological Disorders
7.6.1 Overview
7.6.2 Hematological Disorders: South & Central America Bioproduction Market - Revenue and Forecast to 2030 (US$ Million)
7.7 Diabetes
7.7.1 Overview
7.7.2 Diabetes: South & Central America Bioproduction Market - Revenue and Forecast to 2030 (US$ Million)
7.8 Others
7.8.1 Overview
7.8.2 Others: South & Central America Bioproduction Market - Revenue and Forecast to 2030 (US$ Million)
8. South & Central America Bioproduction Market - Revenue and Forecast to 2030 - by Equipment
8.1 Overview
8.2 South & Central America Bioproduction Market Revenue Share, by Equipment 2022 & 2030 (%)
8.3 Consumables and Accessories
8.3.1 Overview
8.3.2 Consumables and Accessories: South & Central America Bioproduction Market - Revenue and Forecast to 2030 (US$ Million)
8.4 Downstream Equipment
8.4.1 Overview
8.4.2 Downstream Equipment: South & Central America Bioproduction Market - Revenue and Forecast to 2030 (US$ Million)
8.5 Bioreactors
8.5.1 Overview
8.5.2 Bioreactors: South & Central America Bioproduction Market - Revenue and Forecast to 2030 (US$ Million)
8.5.2.1 South & Central America: Bioproduction Market, For Bioreactors by Equipment, 2020-2030 (US$ Million)
8.6 Upstream Equipment
8.6.1 Overview
8.6.2 Upstream Equipment: South & Central America Bioproduction Market - Revenue and Forecast to 2030 (US$ Million)
9. South & Central America Bioproduction Market - Revenue and Forecast to 2030 - by End User
9.1 Overview
9.2 South & Central America Bioproduction Market Revenue Share, by End User 2022 & 2030 (%)
9.3 Biopharmaceutical Companies
9.3.1 Overview
9.3.2 Biopharmaceutical Companies: South & Central America Bioproduction Market - Revenue and Forecast to 2030 (US$ Million)
9.4 Contract Manufacturing Organizations
9.4.1 Overview
9.4.2 Contract Manufacturing Organizations: South & Central America Bioproduction Market - Revenue and Forecast to 2030 (US$ Million)
9.5 Others
9.5.1 Overview
9.5.2 Others: South & Central America Bioproduction Market - Revenue and Forecast to 2030 (US$ Million)
10. South & Central America Bioproduction Market - Revenue and Forecast to 2030 - Country Analysis
10.1 South & Central America: Bioproduction Market
10.1.1 South & Central America: Bioproduction Market Share by Country - 2022 & 2030, (%)
10.1.1.1 Brazil: Bioproduction Market - Revenue and Forecast to 2030 (US$ Million)
10.1.1.2 Brazil: Bioproduction Market- Revenue and Forecasts to 2030 (US$ Million)
10.1.1.2.1 Brazil: Bioproduction Market, by Product, 2020-2030 (US$ Million)
10.1.1.2.2 Brazil: Bioproduction Market, By Application, 2020-2030 (US$ Million)
10.1.1.2.3 Brazil: Bioproduction Market, By Equipment, 2020-2030 (US$ Million)
10.1.1.2.3.1 Brazil: Bioproduction Market, for Bioreactors by Equipment, 2020-2030 (US$ Million)
10.1.1.2.4 Brazil: Bioproduction Market, By End User, 2020-2030 (US$ Million)
10.1.1.3 Argentina: Bioproduction Market - Revenue and Forecast to 2030 (US$ Million)
10.1.1.3.1 Overview
10.1.1.4 Argentina: Bioproduction Market- Revenue and Forecasts to 2030 (US$ Million)
10.1.1.4.1 Argentina: Bioproduction Market, by Product, 2020-2030 (US$ Million)
10.1.1.4.2 Argentina: Bioproduction Market, By Application, 2020-2030 (US$ Million)
10.1.1.4.3 Argentina: Bioproduction Market, By Equipment, 2020-2030 (US$ Million)
10.1.1.4.3.1 Argentina: Bioproduction Market, for Bioreactors by Equipment, 2020-2030 (US$ Million)
10.1.1.4.4 Argentina: Bioproduction Market, By End User, 2020-2030 (US$ Million)
10.1.1.5 Rest of South & Central America: Bioproduction Market - Revenue and Forecast to 2030 (US$ Million)
10.1.1.5.1 Overview
10.1.1.6 Rest of South & Central America: Bioproduction Market - Revenue and Forecast to 2030 (US$ Million)
10.1.1.6.1 Rest of South & Central America: Bioproduction Market, by Product, 2020-2030 (US$ Million)
10.1.1.6.2 Rest of South & Central America: Bioproduction Market, By Application, 2020-2030 (US$ Million)
10.1.1.6.3 Rest of South & Central America: Bioproduction Market, By Equipment, 2020-2030 (US$ Million)
10.1.1.6.3.1 Rest of South & Central America: Bioproduction Market, for Bioreactors by Equipment, 2020-2030 (US$ Million)
10.1.1.6.4 Rest of South & Central America: Bioproduction Market, By End User, 2020-2030 (US$ Million)
11. Bioproduction Market-Industry Landscape
11.1 Overview
11.2 Growth Strategies in the Bioproduction Market
11.3 Inorganic Growth Strategies
11.3.1 Overview
11.4 Organic Growth Strategies
11.4.1 Overview
12. Company Profiles
12.1 Lonza Group AG
12.1.1 Key Facts
12.1.2 Business Description
12.1.3 Products and Services
12.1.4 Financial Overview
12.1.5 SWOT Analysis
12.1.6 Key Developments
12.2 Danaher Corp
12.2.1 Key Facts
12.2.2 Business Description
12.2.3 Products and Services
12.2.4 Financial Overview
12.2.5 SWOT Analysis
12.2.6 Key Developments
12.3 Sartorius AG
12.3.1 Key Facts
12.3.2 Business Description
12.3.3 Products and Services
12.3.4 Financial Overview
12.3.5 SWOT Analysis
12.3.6 Key Developments
12.4 Thermo Fisher Scientific Inc
12.4.1 Key Facts
12.4.2 Business Description
12.4.3 Products and Services
12.4.4 Financial Overview
12.4.5 SWOT Analysis
12.4.6 Key Developments
12.5 Merck KGaA
12.5.1 Key Facts
12.5.2 Business Description
12.5.3 Products and Services
12.5.4 Financial Overview
12.5.5 SWOT Analysis
12.5.6 Key Developments
12.6 F. Hoffmann-La Roche Ltd
12.6.1 Key Facts
12.6.2 Business Description
12.6.3 Products and Services
12.6.4 Financial Overview
12.6.5 SWOT Analysis
12.6.6 Key Developments
12.7 Bio-Rad Laboratories Inc
12.7.1 Key Facts
12.7.2 Business Description
12.7.3 Products and Services
12.7.4 Financial Overview
12.7.5 SWOT Analysis
12.7.6 Key Developments
13. Appendix
13.1 About Us
13.2 Glossary of Terms
List of Tables
Table 1. South & Central America Bioproduction Market Segmentation
Table 2. South & Central America Bioproduction Market, For Bioreactors by Equipment - Revenue and Forecast to 2030 (US$ Million)
Table 3. Brazil: Bioproduction Market, by Product - Revenue and Forecast to 2030 (US$ Million)
Table 4. Brazil: Bioproduction Market, By Application - Revenue and Forecast to 2030 (US$ Million)
Table 5. Brazil: Bioproduction Market, By Equipment - Revenue and Forecast to 2030 (US$ Million)
Table 6. Brazil: Bioproduction Market, for Bioreactors by Equipment - Revenue and Forecast to 2030 (US$ Million)
Table 7. Brazil: Bioproduction Market, By End User - Revenue and Forecast to 2030 (US$ Million)
Table 8. Argentina: Bioproduction Market, by Product - Revenue and Forecast to 2030 (US$ Million)
Table 9. Argentina: Bioproduction Market, By Application - Revenue and Forecast to 2030 (US$ Million)
Table 10. Argentina: Bioproduction Market, By Equipment - Revenue and Forecast to 2030 (US$ Million)
Table 11. Argentina: Bioproduction Market, for Bioreactors by Equipment - Revenue and Forecast to 2030 (US$ Million)
Table 12. Argentina: Bioproduction Market, By End User - Revenue and Forecast to 2030 (US$ Million)
Table 13. Rest of South & Central America: Bioproduction Market, by Product - Revenue and Forecast to 2030 (US$ Million)
Table 14. Rest of South & Central America: Bioproduction Market, By Application - Revenue and Forecast to 2030 (US$ Million)
Table 15. Rest of South & Central America: Bioproduction Market, By Equipment - Revenue and Forecast to 2030 (US$ Million)
Table 16. Rest of South & Central America: Bioproduction Market, for Bioreactors by Equipment - Revenue and Forecast to 2030 (US$ Million)
Table 17. Rest of South & Central America: Bioproduction Market, By End User - Revenue and Forecast to 2030 (US$ Million)
Table 18. Recent Inorganic Growth Strategies in the Bioproduction Market
Table 19. Recent Organic Growth Strategies in the Bioproduction Market
Table 20. Glossary of Terms, Bioproduction Market
List of Figures
Figure 1. South & Central America Bioproduction Market Segmentation, By Country
Figure 2. South & Central America Bioproduction Market: Key Industry Dynamics
Figure 3. South & Central America Bioproduction Market: Impact Analysis of Drivers and Restraints
Figure 4. South & Central America Bioproduction Market Revenue (US$ Mn), 2020 - 2030
Figure 5. South & Central America Bioproduction Market Revenue Share, by Product 2022 & 2030 (%)
Figure 6. Biologics and Biosimilars: South & Central America Bioproduction Market - Revenue and Forecast to 2030 (US$ Million)
Figure 7. Vaccines: South & Central America Bioproduction Market - Revenue and Forecast to 2030 (US$ Million)
Figure 8. Cell and Gene Therapies: South & Central America Bioproduction Market - Revenue and Forecast to 2030 (US$ Million)
Figure 9. Nucleic Acid Therapeutics: South & Central America Bioproduction Market - Revenue and Forecast to 2030 (US$ Million)
Figure 10. Others: South & Central America Bioproduction Market - Revenue and Forecast to 2030 (US$ Million)
Figure 11. South & Central America Bioproduction Market Revenue Share, by Application 2022 & 2030 (%)
Figure 12. Cancer: South & Central America Bioproduction Market - Revenue and Forecast to 2030 (US$ Million)
Figure 13. Cardiovascular Diseases: South & Central America Bioproduction Market - Revenue and Forecast to 2030 (US$ Million)
Figure 14. Rheumatoid Arthritis: South & Central America Bioproduction Market - Revenue and Forecast to 2030 (US$ Million)
Figure 15. Hematological Disorders: South & Central America Bioproduction Market - Revenue and Forecast to 2030 (US$ Million)
Figure 16. Diabetes: South & Central America Bioproduction Market - Revenue and Forecast to 2030 (US$ Million)
Figure 17. Others: South & Central America Bioproduction Market - Revenue and Forecast to 2030 (US$ Million)
Figure 18. South & Central America Bioproduction Market Revenue Share, by Equipment 2022 & 2030 (%)
Figure 19. Consumables and Accessories: South & Central America Bioproduction Market - Revenue and Forecast to 2030 (US$ Million)
Figure 20. Downstream Equipment: South & Central America Bioproduction Market - Revenue and Forecast to 2030 (US$ Million)
Figure 21. Bioreactors: South & Central America Bioproduction Market - Revenue and Forecast to 2030 (US$ Million)
Figure 22. Upstream Equipment: South & Central America Bioproduction Market - Revenue and Forecast to 2030 (US$ Million)
Figure 23. South & Central America Bioproduction Market Revenue Share, by End User 2022 & 2030 (%)
Figure 24. Biopharmaceutical Companies: South & Central America Bioproduction Market - Revenue and Forecast to 2030 (US$ Million)
Figure 25. Contract Manufacturing Organizations: South & Central America Bioproduction Market - Revenue and Forecast to 2030 (US$ Million)
Figure 26. Others: South & Central America Bioproduction Market - Revenue and Forecast to 2030 (US$ Million)
Figure 27. South & Central America: Bioproduction Market, By Key Country - Revenue (2022) (US$ Million)
Figure 28. South & Central America: Bioproduction Market Share by Country - 2022 & 2030, (%)
Figure 29. Brazil: Bioproduction Market- Revenue and Forecasts to 2030 (US$ Million)
Figure 30. Argentina: Bioproduction Market- Revenue and Forecasts to 2030 (US$ Million)
Figure 31. Rest of South & Central America: Bioproduction Market - Revenue and Forecast to 2030 (US$ Million)
Figure 32. Growth Strategies in the Bioproduction Market
1. Lonza Group AG
2. Danaher Corp
3. Sartorius AG
4. Thermo Fisher Scientific Inc
5. Merck KGaA
6. F. Hoffmann-La Roche Ltd
7. Bio-Rad Laboratories Inc
- Save and reduce time carrying out entry-level research by identifying the growth, size, leading players, and segments in the South & Central America bioproduction market.
- Highlights key business priorities in order to assist companies to realign their business strategies.
- The key findings and recommendations highlight crucial progressive industry trends in the South & Central America bioproduction market, thereby allowing players across the value chain to develop effective long-term strategies.
- Develop/modify business expansion plans by using substantial growth offering developed and emerging markets.
- Scrutinize in-depth South & Central America market trends and outlook coupled with the factors driving the South & Central America bioproduction market, as well as those hindering it.
- Enhance the decision-making process by understanding the strategies that underpin commercial interest with respect to client products, segmentation, pricing, and distribution.